{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:20:29Z","timestamp":1778599229297,"version":"3.51.4"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00282","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T07:08:48Z","timestamp":1583996928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma"],"prefix":"10.3389","volume":"10","author":[{"given":"Dirk","family":"Van Gestel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Dragan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mererid","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Budach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.17925\/OHR.2013.09.2.109","article-title":"Technologic advances in external beam radiotherapy for head and neck cancer","volume":"9","author":"Gestel","year":"2012","journal-title":"Oncol. Hematol Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/02841868709104364","article-title":"Optimal dose distribution for eradication of heterogeneous tumors","volume":"26","author":"Brahme","year":"1987","journal-title":"Acta Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.radonc.2012.07.001","article-title":"Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial","volume":"104","author":"Gupta","year":"2012","journal-title":"Radiother Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semradonc.2017.08.004","article-title":"Proton therapy for head and neck cancers","volume":"28","author":"Blanchard","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jnci\/djt031","article-title":"Quality assurance for radiotherapy: a priority for clinical trials","volume":"105","author":"Goodman","year":"2013","journal-title":"JNCI J Natl Cancer Inst"},{"key":"B10","unstructured":""},{"key":"B11","unstructured":"Belgian dosimetry Audits in RadioTherapy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0360-3016(02)03790-2","article-title":"Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas","volume":"55","author":"Khalil","year":"2003","journal-title":"Int J Radiat Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0360-3016(92)90768-D","article-title":"Loss of local control with prolongation in radiotherapy","volume":"23","author":"Fowler","year":"1992","journal-title":"Int J Radiat Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0360-3016(97)00466-5","article-title":"Applying radiobiological principles to combined modality treatment of head and neck cancer\u2014the time factor","volume":"39","author":"Peters","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B15","doi-asserted-by":"publisher","first-page":"012001","DOI":"10.1088\/1742-6596\/573\/1\/012001","article-title":"QA procedures needed for advanced RT techniques and its impact on treatment outcome","volume":"573","author":"Kn\u00f6\u00f6s","year":"2015","journal-title":"J Phys Conf Ser"},{"key":"B16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijrobp.2013.03.036","article-title":"Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review","volume":"87","author":"Fairchild","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0360-3016(91)90132-N","article-title":"Elapsed treatment days-A critical item for radiotherapy quality control review in head and neck trials: RTOG report","volume":"20","author":"Pajak","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-Institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1200\/JCO.2014.56.5218","article-title":"Institutional clinical trial accrual volume and survival of patients with head and neck cancer","volume":"33","author":"Wuthrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1002\/cam4.1756","article-title":"Patient choice for high-volume center radiation impacts head and neck cancer outcome","volume":"7","author":"Naghavi","year":"2018","journal-title":"Cancer Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/hed.20446","article-title":"Importance of patient examination to clinical quality assurance in head and neck radiation oncology","volume":"28","author":"Rosenthal","year":"2006","journal-title":"Head Neck"},{"key":"B23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1200\/JCO.2015.63.9898","article-title":"Importance of radiation oncologist experience among patients with head-and-neck cancer treated with intensity-modulated radiation therapy","volume":"34","author":"Boero","year":"2016","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1002\/cncr.30843","article-title":"Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer","volume":"123","author":"David","year":"2017","journal-title":"Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1001\/jamaoto.2017.1874","article-title":"Association of treatment at high-volume facilities with survival in patients receiving chemoradiotherapy for nasopharyngeal cancer","volume":"144","author":"Verma","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13014-014-0248-9","article-title":"Quality assurance for the EORTC 22071\u201326071 study: dummy run prospective analysis","volume":"9","author":"Fairchild","year":"2014","journal-title":"Radiat Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.radonc.2017.04.019","article-title":"Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV\/p16 negative squamous cell carcinoma of the head and neck: results of the benchmark case procedure","volume":"123","author":"Christiaens","year":"2017","journal-title":"Radiother Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/jicru\/ndq001","volume":"10","year":"2010","journal-title":"J. Int. Comm. Radiat. Units Measure"},{"key":"B29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1259\/bjr\/31966505","article-title":"Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer","volume":"82","author":"Clark","year":"2009","journal-title":"Br J Radiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.zemedi.2009.06.006","article-title":"Physical considerations on discrepancies in target volume delineation","volume":"19","author":"Moeckli","year":"2009","journal-title":"Z Med Phys"},{"key":"B31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","article-title":"CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines","volume":"69","author":"Gr\u00e9goire","year":"2003","journal-title":"Radiother Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","article-title":"Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck","volume":"79","author":"Gr\u00e9goire","year":"2006","journal-title":"Radiother Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","article-title":"Delineation of the primary tumour clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","article-title":"Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019. update","volume":"134","author":"Biau","year":"2019","journal-title":"Radiother Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1748-717X-5-21","article-title":"Decreased 3D observer variation with matched CT-MRI, for target delineation in nasopharynx cancer","volume":"5","author":"Rasch","year":"2010","journal-title":"Radiat Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.radonc.2019.04.006","article-title":"Interobserver variability in delineation of target volumes in head and neck cancer","volume":"137","author":"van der Veen","year":"2019","journal-title":"Radiother Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijrobp.2010.10.019","article-title":"Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer","volume":"82","author":"Nelms","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1748-717X-7-32","article-title":"3D Variation in delineation of head and neck organs at risk","volume":"7","author":"Brouwer","year":"2012","journal-title":"Radiat Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1080\/0284186X.2017.1348622","article-title":"Access to innovative radiotherapy: how to make it happen from an economic perspective?","volume":"56","author":"Lievens","year":"2017","journal-title":"Acta Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.radonc.2014.04.015","article-title":"Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071\u201324071 prospective study for head and neck cancer","volume":"111","author":"Weber","year":"2014","journal-title":"Radiother Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jval.2015.04.003","article-title":"Cost-Effectiveness of reduced waiting time for head and neck cancer patients due to a lean process redesign","volume":"18","author":"Simons","year":"2015","journal-title":"Value Heal"},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1155\/2012\/597467","article-title":"Technical advances and pitfalls in head and neck radiotherapy","volume":"2012","author":"Parvathaneni","year":"2012","journal-title":"J Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.oraloncology.2016.01.001","article-title":"Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?","volume":"54","author":"Bergamini","year":"2016","journal-title":"Oral Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.oraloncology.2018.11.014","article-title":"Radiation therapy quality assurance in head and neck radiotherapy \u2013 moving forward","volume":"88","author":"McDowell","year":"2019","journal-title":"Oral Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.ijrobp.2009.03.059","article-title":"Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study","volume":"76","author":"Den","year":"2010","journal-title":"Int J Radiat Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00282\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T07:08:51Z","timestamp":1583996931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00282\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":48,"alternative-id":["10.3389\/fonc.2020.00282"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00282","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"article-number":"282"}}